The effect of genetic variants in the thrombin activatable fibrinolysis inhibitor (TAFI) gene on TAFI-antigen levels, clot lysis time and the risk of venous thrombosis-Reference-Cited by-同舟云学术

The effect of genetic variants in the thrombin activatable fibrinolysis inhibitor (TAFI) gene on TAFI-antigen levels, clot lysis time and the risk of venous thrombosis

Published:2006-07 Issue:1 Volume:134 Page:92-94
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Martini C.H.,Brandts A.,de Bruijne E.L.E.,van Hylckama Vlieg A.,Leebeek F.W.G.,Lisman T.,Rosendaal F.R.

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.2006.06117.x/fullpdf

Reference12 articles.

1. TAFI, or Plasma Procarboxypeptidase B, Couples the Coagulation and Fibrinolytic Cascades through the Thrombin-Thrombomodulin Complex

2. A novel, possibly functional, single nucleotide polymorphism in the coding region of the thrombin-activatable fibrinolysis inhibitor (TAFI) gene is also associated with TAFI levels

3. Association between thrombin-activatable fibrinolysis inhibitor (TAFI) and clinical outcome in patients with unstable angina pectoris

4. Association between thrombin activatable fibrinolysis inhibitor genotype and levels in plasma: comparison of different assays

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genomic science of risk prediction for venous thromboembolic disease: convenient clarification or compounding complexity;Journal of Thrombosis and Haemostasis;2023-12

2. Assessment of fibrinolytic markers in patients with deep vein thrombosis;Blood Coagulation & Fibrinolysis;2021-12-15

3. Fibrinogen and Antifibrinolytic Proteins: Interactions and Future Therapeutics;International Journal of Molecular Sciences;2021-11-21

4. Thrombin Activatable Fibrinolysis Inhibitor (TAFI): An Updated Narrative Review;International Journal of Molecular Sciences;2021-04-01

5. Carboxypeptidase U (CPU, TAFIa, CPB2) in Thromboembolic Disease: What Do We Know Three Decades after Its Discovery?;International Journal of Molecular Sciences;2021-01-17